“Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy Analysis of 6-Substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester Derivatives”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 16, no. 3, May 2024, pp. 378-86, https://doi.org/10.25004/IJPSDR.2024.160309.